| Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer N Tung, NU Lin, J Kidd, BA Allen, N Singh, RJ Wenstrup, AR Hartman, ... Journal of Clinical Oncology 34 (13), 1460-1468, 2016 | 577 | 2016 |
| Cancer susceptibility gene mutations in individuals with colorectal cancer MB Yurgelun, MH Kulke, CS Fuchs, BA Allen, H Uno, JL Hornick, ... Journal of Clinical Oncology 35 (10), 1086-1095, 2017 | 546 | 2017 |
| A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes SS Buys, JF Sandbach, A Gammon, G Patel, J Kidd, KL Brown, L Sharma, ... Cancer 123 (10), 1721-1730, 2017 | 452 | 2017 |
| Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history KG Chaffee, AL Oberg, RR McWilliams, N Majithia, BA Allen, J Kidd, ... Genetics in Medicine 20 (1), 119-127, 2018 | 160 | 2018 |
| Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of … ET Rosenthal, R Bernhisel, K Brown, J Kidd, S Manley Cancer genetics 218, 58-68, 2017 | 84 | 2017 |
| Adipose tissue gene expression associations reveal hundreds of candidate genes for cardiometabolic traits CK Raulerson, A Ko, JC Kidd, KW Currin, SM Brotman, ME Cannon, Y Wu, ... The American Journal of Human Genetics 105 (4), 773-787, 2019 | 65 | 2019 |
| Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel B Coffee, HC Cox, J Kidd, S Sizemore, K Brown, S Manley, ... Cancer genetics 211, 5-8, 2017 | 55 | 2017 |
| Impact of payer constraints on access to genetic testing P Whitworth, P Beitsch, C Arnell, HC Cox, K Brown, J Kidd, JM Lancaster Journal of oncology practice 13 (1), e47-e56, 2017 | 53 | 2017 |
| Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk GE Idos, AW Kurian, C Ricker, D Sturgeon, JO Culver, KE Kingham, ... JCO Precision Oncology 3, 1-12, 2019 | 51 | 2019 |
| Increased identification of candidates for high-risk breast cancer screening through expanded genetic testing ET Rosenthal, B Evans, J Kidd, K Brown, H Gorringe, M van Orman, ... Journal of the American College of Radiology 14 (4), 561-568, 2017 | 40 | 2017 |
| The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists CJ Cockerell, J Tschen, B Evans, E Bess, J Kidd, KA Kolquist, C Rock, ... Medicine 95 (40), e4887, 2016 | 34 | 2016 |
| Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients JO Culver, CN Ricker, J Bonner, J Kidd, D Sturgeon, R Hodan, K Kingham, ... Cancer 127 (8), 1275-1285, 2021 | 29 | 2021 |
| Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling GS Calip, J Kidd, R Bernhisel, HC Cox, J Saam, GH Rauscher, ... Breast Cancer Research and Treatment 185 (1), 195-204, 2021 | 21 | 2021 |
| Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing D Mancini-DiNardo, T Judkins, J Kidd, R Bernhisel, C Daniels, K Brown, ... BMC Medical Genomics 12, 1-9, 2019 | 21 | 2019 |
| Pancreatic ductal carcinoma risk associated with hereditary cancer-risk genes A Gardiner, J Kidd, MC Elias, K Young, B Mabey, N Taherian, ... JNCI: Journal of the National Cancer Institute 114 (7), 996-1002, 2022 | 19 | 2022 |
| Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma T Eguchi, K Kadota, J Chaft, B Evans, J Kidd, KS Tan, J Dycoco, ... Oncotarget 7 (23), 35241, 2016 | 19 | 2016 |
| The association between age at breast cancer diagnosis and prevalence of pathogenic variants MB Daly, E Rosenthal, S Cummings, R Bernhisel, J Kidd, E Hughes, ... Breast Cancer Research and Treatment 199 (3), 617-626, 2023 | 15 | 2023 |
| Genetic heterogeneity and survival among pancreatic adenocarcinoma (PDAC) patients with positive family history. GM Petersen, KG Chaffee, RR McWilliams, N Majithia, B Allen, J Kidd, ... Journal of Clinical Oncology 34 (15_suppl), 4108-4108, 2016 | 9 | 2016 |
| Multigene assessment of genetic risk for women for two or more breast cancers JN Weitzel, J Kidd, R Bernhisel, S Shehayeb, P Frankel, KR Blazer, ... Breast cancer research and treatment 188, 759-768, 2021 | 8 | 2021 |
| Safety of multiplex gene testing for inherited cancer risk: interim analysis of a clinical trial AW Kurian, G Idos, J Culver, CN Ricker, R Koff, D Sturgeon, K Lowstuter, ... J Clin Oncol 34 (15S), 2016 | 6 | 2016 |
